Since its establishment, the MDA WG has broadened global awareness of market development approaches and helped to refine current understanding of the total market for RH supplies. Technical input from the WG was instrumental in shaping IPPF/ICON’s seminal work on second tier markets; which, in turn, focused the WG's attention on the need to assure the quality of the generic supplies on which those markets largely depend. To this day, the MDA remains in the forefront of Coalition efforts to support implementation of the WHO/UNFPA Prequalification Programme. Finally, the MDA WG is the only WG within the Coalition to have launched its own web-based "key issues guide" on market development approaches. The guide, which is available on the Eldis website, can be accessed by clicking here.
Under the leadership of Ben Light (UNFPA), the WG comprises participants from: Abt Associates, Academy for Educational Development, AltaCare, Bayer-Schering Pharma, Bill & Melinda Gates Foundation, Chemonics, Concept Foundation, Constella Futures International, DKT International, Family Health International, FamyCare, Female Health Company, Fresnius Kabi, International Planned Parenthood Federation, John Snow, Inc, the KfW banking group, Laboratorios Andromaco, Marie Stopes International, Ministry of Foreign Affairs of the Netherlands, PATH, Population Services International, RH Alliance, RHInterchange, Schering-Plough (ex NV Organon), UNFPA, United Kingdom Department for International Development, United States Agency for International Development, World Health Organization, and World Bank.
The MDA WG is currently engaged in the following workstreams:
- Demand creation
- Facilitating the availability of quality generic supplies
- Cultivating links with manufacturers
- Developing indicators to measure market development
- Market Segmentation Toolkit
- Facilitating an enabling environment for the private sector
- Targeted global advocacy for MDAs
